Abstract
摘要
相似文献
1
A new HIV/AIDS drug.
J Ark Med Soc. 1996 Jan;92(8):407.
2
3TC approval may revive AZT's appeal.
Posit Aware. 1996 Jan-Feb;7(1):8-9.
3
Potent new AIDS drugs underscore promise of combination therapy.
AIDS Alert. 1996 Jan;11(1):1-4.
4
Lamivudine as adjunct therapy in HIV.
Am Fam Physician. 1996 Feb 1;53(2):781-2.
5
Roaches of inner space.
GMHC Treat Issues. 1995 Oct;9(10):1, 14-6.
6
Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
AIDS Treat News. 1995 Dec 22(no 237):3.
7
3TC/AZT: just another combination.
GMHC Treat Issues. 1995 Dec;9(12):2.
8
Another protease inhibitor proves highly effective.
Posit Aware. 1996 Sep-Oct;7(5):11.
9
FDA triple header. Food and Drug Administration.
GMHC Treat Issues. 1995 Nov;9(11):1-3.
10
[What should be done after needlestick injuries with possible HIV exposure?].
Fortschr Med. 1996 Feb 10;114(4):23-4.
Zotero 插件